Bowel urgency affects more than a quarter of patients with ulcerative colitis and almost 10% of UC patients in remission. People with poor sleep and high genetic risk have a significantly higher risk of developing digestive diseases. Patients with refractory UC who are treated with JAKi and withdrawal from therapy have high rates of relapse. A third of Black and Hispanic patients with inflammatory bowel disease have post-traumatic stress. "Top-down" treatment is superior to "accelerated step-up" therapy in newly diagnosed Crohn disease. ChatGPT and Google's Bard are not yet a viable source of health-related information for Crohn disease, ulcerative colitis.